
- BioPharm International-05-15-2017
- Volume 2017 eBook
- Issue 1
Insourcing vs Outsourcing: Choosing the Right Strategy
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Aseptic manufacturing is an important part of drug development and commercialization that must be approached with utmost care and attention to detail. Getting a drug product packaged and passing successfully through clinical manufacturing and into the marketplace will depend on many factors, some which are fundamental and straightforward while others require careful consideration of different criteria that can affect each individual situation. The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Download BioPharm International's
.
Articles in this issue
over 8 years ago
Customer Relationship Management in Contract Manufacturingover 8 years ago
Getting Biopharmaceutical Tech Transfer Right the First Timeover 8 years ago
CMOs Tackle New Challengesover 8 years ago
Gearing Up for Biosimilarsover 8 years ago
Operations and Quality Oversight of CMOsover 8 years ago
Quality Metrics and CMO AgreementNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.